J Arnold, K Winthrop, P Emery - Rheumatology, 2021 - academic.oup.com
… in the context of prospective coronavirus disease 2019 (COVID-19) vaccination. But primarily we … COVID-19 needs little introduction, and the three effective vaccines produced by Pfizer (…
… However, we arrived at clinical trials and COVID-19vaccine implementation strategies with relatively sparse datasets about key features including immune priming and comparative, …
… A major threat to the impact of vaccination in preventing disease and death from covid-19 is low uptake of vaccines. In this practice pointer we offer on overview of vaccine hesitancy and …
SS DeRoo, NJ Pudalov, LY Fu - Jama, 2020 - jamanetwork.com
… due to age, immunocompromise, and other preexisting medical conditions, a vaccine … vaccinated if a COVID-19vaccine were available, and only 30% would want to receive the vaccine …
… of getting immunized with a COVID-19vaccine. Thus, the … national assessment of COVID-19 vaccine hesitancy in a … the vaccines will influence the uptake of COVID-19vaccines. …
S Bagcchi - The Lancet. Infectious Diseases, 2021 - ncbi.nlm.nih.gov
… vaccinated in the world's largest COVID-19vaccination campaign that started on Jan 16 in India. The first vaccine … the initial phase of the COVID-19vaccination programme, India aimed …
… be vaccinated against COVID-19 … vaccinated for COVID-19 “when a vaccine becomes available to you” and sociodemographic factors, previous influenza vaccination, general vaccine …
… the acceptance of future COVID-19vaccination, the preference for vaccine attributes and vaccination schedules, as well as the influencing factors on vaccination acceptance among the …
… caused by coronavirus disease 2019 (COVID-19), vaccine development has … of vaccine development is usually long and tedious (Figure 1). The recent advances in COVID-19vaccine …